Prenosis and the Sepsis ImmunoScore covered in today's 360Dx: 360dx.com/business-news/…

Our Sepsis ImmunoScore™, the first FDA-authorized #AI tool for rapid diagnosis and prediction of sepsis, continues to gain recognition in the medical community. Thank you, AmJNurs (American Journal of Nursing), for your coverage. Article here: journals.lww.com/ajnonline/cita… #sepsis

🌍 September is #SepsisAwarenessMonth. Every second counts when it comes to detecting and treating #sepsis. At Prenosis, we’re harnessing the power of #AI to provide earlier, more accurate diagnostics—saving lives with precision. Learn more at prenosis.com

Thank you Crain's Chicago Business for honoring Prenosis's Bobby Reddy, Jr.! And congratulations to the other honorees!

Join us at the Arizona State University Annual National Diagnostics Summit panel, “The AI Revolution" featuring Prenosis's Carlos Lopez-Espina, Tempus's Dr. Ezra Cohen, Arizona State University Dr. Hassan Ghasemzadeh, and Abbott' Brian Renley. Register here: asuevents.asu.edu/event/annual-d…

Prenosis's CEO Bobby Reddy, Jr. was named one of Crain's Chicago Business 's 40 Under 40! Under Bobby's guidance, Prenosis developed the Sepsis ImmunoScore—the first FDA-authorized AI diagnostic for sepsis: chicagobusiness.com/awards/bobby-r…

Thank you, LifeBridge Health, for your support -- lifebridgehealth.org/news/lifebridg… #Sepsis #SepsisImmunoScore

Roche at HLTH – Going boldly, together with you. Join us in shaping the future of healthcare now: spkl.io/6010fRXAo ➡️ Roche booth #1532 ➡️ Global Connector Village #1758-1 Open during booth hours: ⌚ M: 8:00 - 5:45 pm ⌚ Tu: 8:00 - 5:45 pm ⌚ W: 8:00 - 12:00 pm

Powerful JAMA article about #AI regulation. Highlights Prenosis and the Sepsis ImmunoScore™—the first-ever FDA-authorized AI diagnostic for sepsis—as a key example of successfully navigating the FDA’s regulatory process: jamanetwork.com/journals/jama/…

TIME's new cover: Introducing the Best Inventions of 2024 time.com/collection/bes…

Thanks to TIME for recognizing Prenosis and its #SepsisImmunoScore™ as one of the Best Inventions of 2024! Now healthcare providers can better anticipate, diagnose, and treat #sepsis. Read the full story → time.com/7094908/prenos… #TIMEBestInventions #Sepsis #AI

NSF-backed startups are revolutionizing the future. From clean steel and #AI-driven sepsis diagnostics to eco-friendly farming and sustainable batteries, their groundbreaking innovations earned them a spot on TIME's "The Best Inventions of 2024: 200 innovations changing how we

Heading to #IHIForum in Orlando, Dec 8-11? Stop by Booth #416 to see how the FDA-authorized Prenosis's Sepsis ImmunoScore™ helps providers improve SEP-1 bundle compliance and transform sepsis care. Let’s connect and advance healthcare quality together!

Big news: Our study in NEJM AI confirms the Sepsis ImmunoScore™—the first FDA-authorized AI tool for sepsis—has high accuracy for diagnosis and predicting adverse outcomes. A game-changer. Learn more: prnewswire.com/news-releases/… #AI #SepsisCare #HealthcareInnovation

More great news from our member company, Prenosis - a study published by the New England Journal of Medicine shows their Sepsis ImmunoScore tool has both significant diagnostic and predictive power. Take a look at their full press release below: prnewswire.com/news-releases/…

Prenosis (Prenosis), a company founded by Illinois Grainger engineers, had its Sepsis ImmunoScore™ named as one of TIME's Best Inventions of 2024, the first FDA-authorized AI diagnostic and predictive tool for sepsis. 🩸prenosis.com/news/sepsis-im…

Prenosis' AI-powered tool accurately identifies patients at risk of sepsis: study Prenosis #AI #sepsis firstwordhealthtech.com/story/5918796

Looking to improve SEP-1 compliance? The Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic for sepsis, can help. Visit Prenosis's Robin Carver at Booth #416 at #IHIForum2024 to learn how this innovative tool can transform your sepsis diagnostics.

Curious about how #AI is transforming sepsis diagnosis and driving SEP-1 bundle compliance? Join Akhil Bhargava at Booth #416 during the #IHIForum 2024 to learn how cutting-edge tools like the Sepsis ImmunoScore™ are enhancing provider support and improving outcomes.